Universities and colleges
Synergistic Effect of Non-Transmissible Sendai Virus Vector Encoding c-myc Suppressor FUSE-Binding Protein-Interacting Repressor Plus Cisplatin in Malignant Pleural Mesothelioma Treatment
A recent study published in Cancer Science has revealed promising therapeutic potential for the treatment of malignant pleural mesothelioma (HMPM) using a combination of a non-transmissible Sendai virus vector encoding the c-myc suppressor FUSE-binding protein-interacting repressor (FIR) and cisplatin. The study, conducted by researchers from Chiba University in Japan, demonstrated